HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.

AuthorsAnna López-Ferrer, Joan Dalmau, María Teresa Fernández-Figueras, Lluís Puig
JournalCutis (Cutis) Vol. 93 Issue 3 Pg. E6-7 (Mar 2014) ISSN: 2326-6929 [Electronic] United States
PMID24738108 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Keratolytic Agents
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Acitretin
  • Etanercept
Topics
  • Acitretin (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Drug Therapy, Combination
  • Etanercept
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Infliximab
  • Keratolytic Agents (therapeutic use)
  • Keratosis, Actinic (drug therapy)
  • Male
  • Middle Aged
  • Photochemotherapy (adverse effects)
  • Pityriasis Rubra Pilaris (drug therapy, etiology, pathology)
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: